Preclinical studies of amixicile, a systemic therapeutic developed for treatment of Clostridium difficile infections that also shows efficacy against Helicobacter pylori
about
A Review of Experimental and Off-Label Therapies for Clostridium difficile InfectionRole of Serum Amyloid A, Granulocyte-Macrophage Colony-Stimulating Factor, and Bone Marrow Granulocyte-Monocyte Precursor Expansion in Segmented Filamentous Bacterium-Mediated Protection from Entamoeba histolytica.Synthesis and Antimicrobial Evaluation of Amixicile-Based Inhibitors of the Pyruvate-Ferredoxin Oxidoreductases of Anaerobic Bacteria and Epsilonproteobacteria.Amixicile, a novel strategy for targeting oral anaerobic pathogens.
P2860
Preclinical studies of amixicile, a systemic therapeutic developed for treatment of Clostridium difficile infections that also shows efficacy against Helicobacter pylori
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Preclinical studies of amixici ...... cy against Helicobacter pylori
@ast
Preclinical studies of amixici ...... cy against Helicobacter pylori
@en
type
label
Preclinical studies of amixici ...... cy against Helicobacter pylori
@ast
Preclinical studies of amixici ...... cy against Helicobacter pylori
@en
prefLabel
Preclinical studies of amixici ...... cy against Helicobacter pylori
@ast
Preclinical studies of amixici ...... cy against Helicobacter pylori
@en
P2093
P2860
P50
P356
P1476
Preclinical studies of amixici ...... cy against Helicobacter pylori
@en
P2093
Alexandra M Bruce
Paul S Hoffman
Timothy L Macdonald
P2860
P304
P356
10.1128/AAC.03112-14
P407
P50
P577
2014-06-02T00:00:00Z